Skip to content

Monitoring Changes in Physiological Parameters by Utilization of the Combined Physiological Activity Index (CPAI)

Monitoring Physiological Activity Cause by Changes in Physiological Parameters Via Utilization of the Combined Physiological Activity Index (CPAI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03508063
Enrollment
70
Registered
2018-04-25
Start date
2017-12-20
Completion date
2018-05-21
Last updated
2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

A clinical trial to validate the MCPM (Multi-parameter Combined Physiological Signal-based Monitoring), in estimating physiological activity level, at rest, previous and following stimuli.

Detailed description

The Multi-parameter Combined Physiological Signal-based Monitoring (MCPM) system is a non-invasive multi-parameter physiological monitoring system, intended for continuous . acquisition, analysis and display of physiological signals and a Combined Physiological Activity Index (CPAI). Subjects who meet the study inclusion and exclusion criteria will be enrolled to the study and their physiological measures, at rest and during exposure to the thermal and stressogenic physical stimuli will be recorded by the MCPM system. All subjects will be recorded according to a standard procedure; subjects will be lying in the supine position and will be instructed to avoid any movements. The experimenter will connect the sensors (MCPM finger probe). During the experimental session, different thermal stimuli will be administrated via the cold pressor test, with 10-20 minutes of non-stimuli interval. The last stimuli is an stressogenic physical preformed by the subject. 1-2 weeks following the first visit, about half of the subjects will be invited to a second visit, identical study visit, to assess the between session test-retest reliability of the signals. During the second visit, CPAI will be measured again under randomize thermal stimuli and an additional 3 Celsius degrees cold stimuli.

Interventions

None listed

Sponsors

Medasense Biometrics Ltd
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 \< 65 years old * Signing an Informed Consent Form (ICF) * Healthy participant * No medication/drugs were taken in the last week * No usage of chronic medication in the last 3 months (except non-pregnancy pills) * Blood Pressure \< (90,140), Heart Rate \< 100pps at rest * No alcohol usage during the last 48 hours

Exclusion criteria

* Medication/drugs were taken in the last week (not including non-pregnancy pills) * Alcohol usage during the last 48 hours * Caffeine and smoking in the last 3 hours * Pregnant women * Inability to comply with the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Performance of the CPAI Index6 monthsdifferentiation between periods in which the subjects were exposed to various intensities of thermal stimuli.

Secondary

MeasureTime frameDescription
Accuracy of the physiological parameters of the MCPM6 monthscomparison to a gold standard device (GE and Procomp system)
Test re-test reliability6 monthscomparison of two repeated CPAI and physiological parameters measures of the same individual at two different study visits

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026